GS1 US Introduces Best Practice Guidance for Pharmaceutical Saleable Returns
Why now
Thesis: Industry best-practice doc, no financials
Catalyst to watch: DSCSA enforcement deadlines
Main risk: Adoption may be slow
Why it matters
Returns-handling standards affect pharma logistics compliance costs, not near-term earnings.
Details
New resource provides a common framework to help trading partners verify returned products, resolve exceptions and support DSCSA recordkeeping EWING, N.J., Sept. 23, 2026 /PRNewswire/ -- GS1 US has published "Best Practice Guidance for the Handling of Saleable Return Transactions," a new...
Related assets & topics
HealthcareSources
- prnewswire · 2026-09-23 13:15 UTC